Skip to content
10-K

Annual Report

RA PHARMACEUTICALS, INC.

0001047469-20-001072

← back to feed
Filed
Feb 27, 2020 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Feb 18, 2020 47.33M sh
Capex FY 2019 · Dec 31, 2019 $865K
Capex FY 2019 · Dec 31, 2018 $1.03M
Operating Cash Flow FY 2019 · Dec 31, 2019 −$87.36M
Operating Cash Flow FY 2019 · Dec 31, 2018 −$54.95M
Cash And Equivalents FY 2019 · Dec 31, 2019 $264.99M
Cash And Equivalents FY 2019 · Dec 31, 2018 $209.82M
Stockholders Equity FY 2019 · Dec 31, 2019 $262.11M
Stockholders Equity FY 2019 · Dec 31, 2018 $207.12M
Stockholders Equity FY 2019 · Dec 31, 2017 $69.18M
Current Liabilities FY 2019 · Dec 31, 2019 $18.58M
Current Liabilities FY 2019 · Dec 31, 2018 $10.2M
Total Liabilities FY 2019 · Dec 31, 2019 $22.04M
Total Liabilities FY 2019 · Dec 31, 2018 $12.1M
Current Assets FY 2019 · Dec 31, 2019 $274.69M
Current Assets FY 2019 · Dec 31, 2018 $212.41M
Total Assets FY 2019 · Dec 31, 2019 $284.15M
Total Assets FY 2019 · Dec 31, 2018 $219.22M
Sga Expense FY 2019 · Dec 31, 2019 $27.34M
Sga Expense FY 2019 · Dec 31, 2018 $14.44M
Rd Expense FY 2019 · Dec 31, 2019 $82.64M
Rd Expense FY 2019 · Dec 31, 2018 $54.45M
Net Income FY 2019 · Dec 31, 2019 −$36.78M
Net Income FY 2019 · Dec 31, 2019 −$102.69M
Net Income FY 2019 · Sep 30, 2019 −$24.98M
Net Income FY 2019 · Jun 30, 2019 −$21.9M
Net Income FY 2019 · Mar 31, 2019 −$19.04M
Net Income FY 2019 · Dec 31, 2018 −$16.2M
Net Income FY 2019 · Dec 31, 2018 −$64.94M
Net Income FY 2019 · Sep 30, 2018 −$16.5M
Net Income FY 2019 · Jun 30, 2018 −$15.75M
Net Income FY 2019 · Mar 31, 2018 −$16.5M
Operating Income FY 2019 · Dec 31, 2019 −$106.98M
Operating Income FY 2019 · Dec 31, 2018 −$66.39M
Revenue FY 2019 · Dec 31, 2019 $3M
Revenue FY 2019 · Dec 31, 2018 $2.5M